Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Y D Lapierre"'
Autor:
Diego Rosales, Bishan Saxena, Peter Turner, Robin T. Reesal, Jacques Plamondon, Monica Bologa, Pierre Vincent, Raymond W. Lam, Peter H. Silverstone, Ronald A. Remick, Cara D.L. Kroft, Y D Lapierre, Richard Payeur, David Bakish
Publikováno v:
Journal of Clinical Psychopharmacology. 18:268-273
Ipsapirone, an azapirone with 5-hydroxytryptamine (5-HT1A) partial agonist activity, has been shown in preliminary studies to be effective in the treatment of major depressive disorder. This 8-week, randomized, double-blind study compared the efficac
Publikováno v:
The Canadian Journal of Psychiatry. 40:370-377
Objectif : Evaluer, grâce a une analyse cout/efficacite, les repercussions economiques possibles de l'introduction de nouveaux antidepresseurs plus dispendieux sur le cout global du traitement. Methode : Dans le cadre de cette analyse, on a elabore
Autor:
Y D Lapierre
Publikováno v:
Acta Psychiatrica Scandinavica. 89:42-48
For a number of years, dysthymia was considered to be non-responsive to antidepressant treatment. During the last decade, early studies with tricyclic antidepressants (TCAs) demonstrated the superiority of the TCAs over placebo. The side effect profi
Publikováno v:
International Clinical Psychopharmacology. 8:87-90
Publikováno v:
Canadian Medical Association journal. 124(3)
Autor:
E. Horn, David Bakish, Verner J. Knott, Lisa Griffiths, Duncan De Lugt, Y D Lapierre, M. Browne
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15:257-262
1. 1. Psychomotor slowing in depression is frequently reflected by delayed reaction times (RT). 2. 2. The role of central arousal mechanisms in response slowing was examined by comparing scalp-recorded slow negative potentials of depressed patients w
Publikováno v:
International Clinical Psychopharmacology. 5:103-110
This paper reports a double-blind cross-over study (1) to investigate the efficacy of lithium carbonate to produce rapid relief of major depression in patients who were previously unresponsive to at least 4 weeks of antidepressant therapy; (2) to stu
Autor:
K Grafford, B Gauthier, A Labelle, M D Teehan, Y D Lapierre, A.G. Awad, B. Saxena, E Busse, B. Jones, L Claesson, L K Oyewumi, R Manchanda, C. Angus, P Williamson, P Vincent, Y J Lavallee, M A Wolf, R Carle, J F Denis, Ashok Malla
Publikováno v:
International clinical psychopharmacology. 14(2)
The primary objective of this study was to evaluate the efficacy, safety and tolerability of remoxipride (controlled release) versus haloperidol in patients with negative symptoms. The study comprised a multicentre, randomised, double-blind, parallel
Autor:
Y D Lapierre, K. G. Jostell
Publikováno v:
Acta Psychiatrica Scandinavica. 82:48-50
The possible relationship between plasma concentration of remoxipride and antipsychotic effect/adverse symptoms has been evaluated in a 6-week double-blind dose-finding study in schizophrenic patients. The study comprised 3 parallel groups with fixed